Brief: Shilpa Medicare Receives CDSCO Approval For Nor Ursodeoxycholic Acid Tablets
13/02/2025 08:41
Feb 13 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* SHILPA MEDICARE LTD - RECEIVES CDSCO APPROVAL FOR NOR
URSODEOXYCHOLIC ACID TABLETS
* SHILPA MEDICARE LTD - CDSCO RECOMMENDS MARKETING
AUTHORIZATION
FOR NAFLD TREATMENT
Source text: ID:nBSE1MjXx2
Further company coverage: SHME.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026